Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia.
暂无分享,去创建一个
S. Baker | Shuiying Hu | M. Roberts | C. Stewart | J. Buaboonnam | H. Inaba | D. Turner | S. Orwick | L. Janke | E. Zimmerman | A. Ramachandran | Jassada Buaboonnam